BPA Call W91YTZ23A0014-W91YTZ26FA006
- Not listed
- Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
- Cerilliant Corporation was awarded a $13,064.06 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide laboratory supplies. The contract has no set-aside designation and runs from the May 19, 2023 award date through the May 19, 2023 completion date. Cerilliant will deliver the requested chemical and biological reference standards and calibrators to support the agency's laboratory programs from their place of performance in Fort Meade, Maryland. No...
- Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
- The Department of the Army Medical Command awarded a firm fixed price blanket purchase agreement call contract valued at twenty thousand dollars to Cerilliant Corporation for certified drug reference standards. The contract has a period of performance through August 1, 2022 to support the Medical Command's drug testing and certification programs. Cerilliant will provide reference standards to the Medical Command's laboratories located at Fort Meade, Maryland to assist in their efforts to...
- This is a $169,057 firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards, calibrators, reagents, and laboratory supplies. The contract is for the delivery of DLS Traceable Opioid Kits and has an ultimate completion date of September 28, 2023. Cerilliant Corporation is a global leader in certified reference materials and has secured...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Cepheid Inc. for COVID-19 testing supplies with a ceiling value of $914,982.50 under a firm fixed-price contract structure. The award, executed on January 8, 2026, with an ultimate completion date of January 7, 2027, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. Performance will take place at Fort Belvoir, Virginia, and the contract includes no...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $92,321.88 firm-fixed-price delivery order has a period of performance through May 23, 2023. The contract award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., that serves as the primary vehicle for the company to provide a...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,836.50 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) responsible for providing medical supplies to military healthcare facilities. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies,...
- W91YTZ23A0014Blanket Purchase Agreement
- W91YTZ23A0014-W91YTZ26FA006BPA Call
The Defense Health Agency awarded a $11,009.05 firm fixed-price Blanket Purchase Agreement (BPA) call to Cerilliant Corporation on January 5, 2026, for laboratory supplies to be delivered to Fort Meade, Maryland no later than January 22, 2026, with a final completion date of February 1, 2026. This contract award carries no set-aside designation and represents a call against one of Cerilliant's existing indefinite delivery vehicles with the Defense Health Agency. Cerilliant Corporation, a Texas-based manufacturer specializing in certified reference materials and laboratory supplies, has been a sustained federal supplier for over 30 years and serves as a critical provider of drug reference standards, chemical and biological standards, and calibrators used in forensic toxicology and drug screening applications. This award reflects Cerilliant's established role as a specialized supplier to the Defense Health Agency, leveraging its expertise in ISO-certified reference materials for military medical readiness and forensic toxicology operations at Fort Meade. The company maintains multiple active BPAs with the Defense Health Agency, including a primary $250,000 agreement running through September 2028 and a $746,914.62 BPA extending through October 2027, demonstrating the agency's ongoing reliance on Cerilliant's specialized capabilities for laboratory materials that support service member health and readiness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 1/8/26 |